Skip to main content
Download PDF
Download ePub

Erratum to Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

Journal of Experimental & Clinical Cancer Research volume 29, Article number: 105 (2010) Cite this article

The Original Article was published on 07 July 2010

Correction

After the publication of this research article [1], the authors noticed an error with Figure 1. Graph D which should have indicated miR-106b expression levels in renal parenchyma (RP) and renal cell carcinomas (RCC), was mistakenly displayed as a duplicate of Graph C. The corrected Figure 1 is provided here.

figure 1

Figure 1

References

  1. Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R: Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. Journal of Experimental & Clinical Cancer Research. 2010, 29: 90-10.1186/1756-9966-29-90.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Zluty kopec 7, Brno, Czech Republic

    Ondrej Slaby, Radek Lakomy, Marek Svoboda, Alexandr Poprach & Rostislav Vyzula

  2. Masaryk Memorial Cancer Institute, Department of Oncological and Experimental Pathology, Zluty kopec 7, Brno, Czech Republic

    Pavel Fabian

  3. Babak Research Institute, University Cell Immunotherapy Center, Kamenice 5, Brno, Czech Republic

    Ondrej Slaby & Jaroslav Michalek

  4. Masaryk University, Faculty of Science, Department of Biochemistry, Kotlarska 2, Brno, Czech Republic

    Jana Jancovicova

  5. University Hospital Brno, Department of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic

    Leos Kren

Authors
  1. Ondrej Slaby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jana Jancovicova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Radek Lakomy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marek Svoboda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alexandr Poprach
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pavel Fabian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Leos Kren
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jaroslav Michalek
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rostislav Vyzula
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ondrej Slaby.

Additional information

The online version of the original article can be found at 10.1186/1756-9966-29-90

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Slaby, O., Jancovicova, J., Lakomy, R. et al. Erratum to Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res 29, 105 (2010). https://doi.org/10.1186/1756-9966-29-105

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1756-9966-29-105

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us